How to cite this paper
APA: Lelyukh, M., Savchenko, A., Kalytovska, M., Zhukrovska, M., Chaban, I., Vergun, A., Shelepeten, L & Chaban, T. (2025). Pharmacological profile of condensed heterocyclic compounds based on functionally substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles: A review. Current Chemistry Letters, 14(3), 567-578.
Chicago/Turabian: Lelyukh, M., Savchenko, A., Kalytovska, M., Zhukrovska, M., Chaban, I., Vergun, A., Shelepeten, L & Chaban, T. 2025. "Pharmacological profile of condensed heterocyclic compounds based on functionally substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles: A review." Current Chemistry Letters 14, no. 3 (2025): 567-578.
AMA: Lelyukh, M., Savchenko, A., Kalytovska, M., Zhukrovska, M., Chaban, I., Vergun, A., Shelepeten, L & Chaban, T. Pharmacological profile of condensed heterocyclic compounds based on functionally substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles: A review. Current Chemistry Letters. 2025;14(3):567-578.
References
1. Saini M.S., Kumar A., Dwivedi J., and Singh R. (2013) A review: Biological significances of heterocyclic compounds. Int. J. Pharm. Sci. Res., 4 (3) 66-77.
2. Al-Mulla A. (2017) A review: Biological importance of heterocyclic compounds. Der Pharma Chemica, 9 (13) 141-147.
3. Hamoud M.M.S., Osman N.A., Rezq S., Abd El-Wahab H.A.A., Hassan A.E.A., Abdel-Fattah H.A., Romero D.G., and Chanim A.M. (2022) Design and synthesis of novel 1,3,4-oxadiazole and 1,2,4-triazole derivatives as cyclooxygenase-2 inhibitors with anti-inflammatory and antioxidant activity in LPS-stimulated RAW264.7 macrophages. Bioorg. Chem., 124 105808. https://doi.org/10.1016/j.bioorg.2022.105808
4. Chaban T.I., Matiichuk Y.E., Horishny V.Y., Chaban I.G., and Matiychuk V.S. (2020) Synthesis and anticancer activity of 2-aryl-3-methylbenzofuro[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-dione and 2-aryl-3,7,9-trimethylpyrido[3',2':4,5]thieno[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-diones. Russ. J. Org. Chem., 56 813-818. http://dx.doi.org/10.1134/S1070428020050139
5. Pone K.B., Dalhatou S., Paumo H.K., Katata-Seru L.M., and Ferreira E.I. (2022) Triazole-containing heterocycles: Privileged scaffolds in anti-Trypanosoma Cruzi drug development. Curr. Drug Targets, 23 (1) 33-59. https://doi.org/10.2174/1389450122666210412125643
6. Lelyukh M., Demchuk I., Harkov S., Chaban T., Drapak I., Chaban I., Shelepeten L., and Matiychuk V. (2020) A review on synthetic routes for obtaining of 2,5-disubstituted 1,3,4-oxadiazoles via cyclodehydration and oxidative cyclization reactions. Biointerface Res. Appl. Chem., 10 (4) 5960-5971. https://doi.org/10.33263/BRIAC104.960971
7. Longo Jr, L.S. and Siqueira F.A. (2024) Synthesis of imidazo[2,1-b]thiazol-5-amines using Groebke-Blackburn-Bienaymé multicomponent reaction (microreview). Chem. Heterocycl. Compd., 60 (7/8) 339-341.
8. Chaban T.I., Lelyukh M.I., Chaban I.H., and Kasyanchuk O.Y. (2024) Approaches to the synthesis of thiazolo[3,2-a]pyridines (microreview). Chem. Heterocycl. Compd., 60 (3/4) 124-126.
9. Drapak I., Chaban T., Foliush V., and Matiychuk V. (2020) Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl)thiazol-2-ylimino]thiazolidin-4-ones. Biointerface Res. Appl. Chem., 10 (3) 5507-5511. https://doi.org/10.33263/BRIAC103.507511
10. Subtelna I., Kryshchyshyn-Dylevych A., Jia R., Lelyukh M., Ringler A., Kubicek S., Zagrijtschuk O., Kralovics R., and Lesyk R. (2021) 5-Arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones with selective inhibitory activity against some leukemia cell line. Arch. Pharm., 354 (4) 2000342. https://doi.org/10.1002/ardp.202000342
11. Сhulovska Z., Chaban T., Drapak I., Matiychuk V., Chaban I., and Nektegaev I. (2021) Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents. Biointerface Res. Appl. Chem., 11 (1) 8009-8017. https://doi.org/10.33263/BRIAC111.80098017
12. Lingappa M., Guruswamy V., and Bantal V. (2021) Synthesis and characterization of 4-amino-4H-1,2,4-triazole derivatives: Anticonvulsant activity. Curr. Chem. Lett., 10 (1) 33-42. https://doi.org/10.5267/j.ccl.2020.7.002
13. Lelyukh M., Matiichuk Yu., Flud V., Chaban I., and Ogurtsov V. (2022) Synthesis and antioxidant properties of novel 2-(2,4-dioxothiazolidin-5-ylidene)-acetamides containing 1,3,4-thia/oxadiazole moieties. Biointerface Res. Appl. Chem., 12 (5) 6710-6722. https://doi.org/10.33263/BRIAC125.67106722
14. Lelyukh M., Halevych H., Zhukrovska M., Semiion-Luchyshyn O., and Kalytovska M. (2023) Synthesis of 5-aryl/heterylidene substituted 2-imino-4-thiazolidinones possessing 1,3,4-thiadiazole moiety and their antitrypanosomal activity. Curr. Chem. Lett., 12 (2) 413-420. https://doi.org/10.5267/j.ccl.2022.11.005
15. Chaban T.I., Klenina O.V., Chaban I.H., and Lelyukh M.I. (2024) Recent advances in the synthesis of thiazolo[4,5-b]pyridines. Part 2: Focus on thiazole annulation to pyridine ring (microreview). Chem. Heterocycl. Compd., 60, (3-4) 130-132.
16. Chulovska Z., Chaban T., Savchenko A., Komarytsya O., Dasho M., Lelyukh M., Chaban I., and Ogurtsov V. (2025) Antioxidant properties of some 4-arylimino-thiazolidin-2-ones. Curr. Chem. Lett., 14 (2) 365-372. https://doi.org/10.5267/j.ccl.2024.11.001
17. Charitos G., Trafalis D.T., Dalezis P., Polamitis C., Sarli V., Zoumpoulakis P., and Camoutsis C. (2019) Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives. Arab. J. Chem., 12 (8) 4784-4794. https://doi.org/10.1016/j.arabjc.2016.09.015
18. Pundeer R., Ranjan P., Prakash R., and Joshi R. (2018) Synthesis of novel 6-(1H-pyrazol-4-yl)-[1,2,4]triazolo[3,4-b]thiadiazoles as potential antimicrobial agents. Lett. Org. Chem., 15 (2) 92-97. https://doi.org/10.2174/1570178614666170907121125
19. Idrees M., Kola S.S., and Siddiqui N.J. (2019) Facile synthesis, characterization and antimicrobial activities of novel 6-amino triazolo-thiadiazoles integrated with benzofuran and pyrazole moieties. Oriet. J. Chem., 35 (6) 1712-1717. http://dx.doi.org/10.13005/ojc/350612
20. Gao W., Zhang Y., Chen L., Liu X., Li K., Han L., Yu Z., Ren J., Tang L., and Fan. Z. (2022) Novel [1,2,4]-triazolo[3,4-b]thiadiazoles as potent pyruvate kinase inhibitors for fungal control. J. Agric. Food Chem., 70 (33) 10170-10181. https://doi.org/10.1021/acs.jafc.2c03758
21. Maddila S., Gorle S., Singh M., Lavanya P., and Jonnalagadda S.B. (2013) Synthesis and anti-inflammatory activity of fused 1,2,4-triazolo-[3,4-b] [1,3,4]thiadiazole derivatives of phenothiazine. Lett. Drug. Des. Discov., 10 (10) 977-983.
22. Dighe A.S. and Sen A.K. (2021) In silico investigation and molecular docking study of triazolo-thiadiazole derivatives for antimicrobial, anti-inlammatory and anti-diabetic activity. Indian J. Pharm. Educ. Res., 55 (4) 1125-1144. https://doi.org/10.5530/ijper.55.4.213
23. Himaja M., Prathap K.J., and Mali S.V. (2012) Facile synthesis of 3,6-disubstituted-1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazoles via oxidative cyclization of n-heteroaryl-substituted hydrazones and their biological activity. J. Heterocycl. Chem., 49 (4) 823-828. https://doi.org/10.1002/jhet.870
24. Khatoon Y., Singh V., and Sarafroz M. (2018) Anticonvulsant and neurotoxicity evaluation of some fused 1,2,4-triazole-[3,4-b]-1,3,4-thiadiazole derivatives. Int. J. Pharm. Sci. Rev. Res., 48 (2) 70-78.
25. Tozkoparan B., Pery Aytac S., Gursoy S., Gunal S., and Aktay G. (2012) Novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives as dual analgesic/anti-inflammatory and antimicrobial agents. Lett. Drug. Des. Discov., 9 (2) 204-212.
26. Jubie S., Ramesh P.N., Dhanabal P., Kalirajan R., Muruganantham N., and Antony A.S. (2012) Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues. Eur. J. Med. Chem., 54 931-935. https://doi.org/10.1016/j.ejmech.2012.06.025
27. Akhter Mohd. W., Hassan Mohd. Z., and Amir Mohd. (2014) Synthesis and pharmacological evaluation of 3-diphenylmethyl-6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles: A condensed bridgehead nitrogen heterocyclic system. Arab. J. Chem, 7 (6) 955-963. https://doi.org/10.1016/j.arabjc.2014.05.036
28. Wu J., Li J., Xu M.-H., and Liu D. (2014) Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole. Bioorg. Med. Chem. Lett., 24 (14) 3050-356. https://doi.org/10.1016/j.bmcl.2014.05.028
29. Llona-Minguez S., Höglund A., Wiita E., Almlöf I., Mateus A., Calderón-Montaño J.M., Cazares-Körner C., Homan E., Loseva O., Baranczewski P., Jemth A.-S., Häggblad M., Martens U., Lundgren B., Artursson P., Lundbäck T., Jensen A.J., Berglund U.W., Scobie M., and Helleday T. (2017) Identification of triazolothiadiazoles as potent inhibitors of the dCTP pyrophosphatase 1. J. Med. Chem., 60 (5) 2148-2154. https://doi.org/10.1021/acs.jmedchem.6b01786
30. Bonafoux D., Nanthakumar S., Bandarage U.K., Memmott C., Lowe D.B., Aronov A.M., Rao G.B., Bonanno K., Coll J., Leeman J., Lepre C.A., Lu F., Perola E., Rijnbrand R., Taylor W.P., Wilson D., Zhou Y., Zwahlen J., and ter Haar E. (2016) Fragment-based discovery of dual JC virus and BK virus helicase inhibitors. J. Med. Chem., 59 (15) 7138-7151. https://doi.org/10.1021/acs.jmedchem.6b00486
31. Zhang J., Liu H., Zhu K., Gong S., Dramsi S., Wang Y.-T., Li J., Chen F., Zhang R., Zhou L., Lan L., Jiang H., Schneewind O., Luo C., and Yang C.-G. (2014) Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase. Proc. Natl. Acad. Sci., 111 (37) 13517-13522. https://doi.org/10.1073/pnas.1408601111
32. Fan J.-Z., Li J.-P., Zhang L.-P., Zhang L.-G., and Wang D.-Z. (2015) New CuII and CdII metal-organic coordination polymers with 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole ligands: Syntheses, structures and luminescent properties. J. Chin. Chem. Soc., 62 (9) 786-792.
33. Jubie S., Bincy B., Begam A.J., Ashish W., Kalirajan R., and Azam Md A. (2018) A new class of human fatty acid synthase inhibitors: Synthesis and their anticancer evaluation. Indian J. Chem., 57B 671-678.
34. Lelyukh M., Adamchuk S., Harkov S., Chaban I., Demchuk I., Shelepeten L., and Chaban T. (2018) Synthetic approaches, chemical modification and biological activity of non-condensed 1,3,4-thiadiazole derivatives: A review. Pharmacia, 65 (4) 72-88.
35. Lelyukh M., Zhukrovska M., Komarenska Z., Flud V., and Harkov S. (2023) Synthetic approaches, modification ability and biological activity of 1,3,4-thiadiazole based [5+5] annelated heterosystems: Mini-review. Curr. Chem. Lett., 12 (4) 769-780. https://doi.org/10.5267/j.ccl.2023.4.004
36. Lelyukh M., Paliy A., Zhukrovska M., Kalytovska M., Chaban I., Shelepeten L., and Chaban T. (2024) A review on synthetic approaches for obtaining and chemical modification of 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole based heterocyclic compounds. Curr. Chem. Lett., 13 (4) 737-752. https://doi.org/10.5267/j.ccl.2024.3.007
37. Lelyukh M.I., Komarenska Z.M., Chaban T.I., and Chaban I.H. (2024) An overview of the synthetic routes toward [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles (microreview). Chem. Heterocycl. Compd., 60 (7/8) 342-344.
38. Xu Q., Sun M., Bai Z., Wang Y., Wu Y., Tian H., Zuo D., Guan Q., Bao K., Wu Y., and Zhang W. (2017) Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. Eur. J. Med. Chem., 139 242-249. https://doi.org/10.1016/j.ejmech.2017.05.065
39. Sunil D., Isloor A.M., Shetty P., Satyamoorthy K., and Prasad A.S.B. (2011) Synthesis, characterization, antioxidant, and anticancer studies of 6-[3-(4-chlorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b][1,3,4]thiadiazole in HepG2 cell lines. Med. Chem. Res., 20 1074-1080. https://doi.org/10.1007/s00044-010-9436-9
40. Trafalis D.T., Sagredou S., Dalezis P., Voura M., Fountoulaki S., Nikoleousakos N., Almpanakis K., Deligiorgi M.V., and Sarli V. (2021) Anticancer activity of triazolo-thiadiazole derivatives and inhibition of AKT1 and AKT2 activation. Pharmaceutics, 13 493. https://doi.org/10.3390/pharmaceutics13040493
41. Liu X.-J., Liu H.-Y., Wang H.-X., Shi Y.-P., Tang R., Zhang S., and Chen B.-Q. (2019) Synthesis and antitumor evaluation of novel fused heterocyclic 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. Med. Chem. Res., 28 1718-1725. https://doi.org/10.1007/s00044-019-02409-2
42. Zhang L., Zhao J., Zhang B., Lu T., and Chen Y. (2018) Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. Eur. J. Med. Chem., 150 809-816. https://doi.org/10.1016/j.ejmech.2018.03.049
43. Hamdy R., Jones A.T., El-Sadek M., Hamoda A.M., Shakartalla S.B., Al Shareef Z.M., Soliman S.S.M., and Westwell A.D. (2021) New bioactive fused triazolothiadiazoles as Bcl-2-Targeted anticancer agents. Int. J. Mol. Sci., 22 (22) 12272. https://doi.org/10.3390/ijms222212272
44. Sagredou S., Dalezis P., Nikoleousakos N., Nikolaou M., Voura M., Almpanakis K., Panayiotidis M.I., Sarli V., and Trafalis D.T. (2020) 3,6-Disubstituted 1,2,4-triazolo[3,4-b]thiadiazoles with anticancer activity targeting topoisomerase II alpha. Onco Targets Ther., 13 7369-7386. http://doi.org/10.2147/OTT.S254856
45. Barash U., Rangappa S., Mohan C.D., Vishwanath D., Boyango I., Basappa B., Vlodavsky I., and Rangappa K.S. (2021) New heparanase-inhibiting triazolo-thiadiazoles attenuate primary tumor growth and metastasis. Cancers, 13 (12) 2959. https://doi.org/10.3390/cancers13122959
46. Sahu J.K., Ganguly S., and Kaushik A. (2014) Synthesis of some novel heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] thiadiazole derivatives as possible antimicrobial agents. J. Appl. Pharm. Sci., 4 (02) 081-086. https://doi.org/10.7324/JAPS.2014.40214
47. Triloknadh S., Rao C.V., Nagaraju B., Balagi H., and Balaji M. (2018) Design and synthesis of novel 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]1,3,4-thiadiazole derivatives and their antimicrobial studies. Eur. J. Biomed. Pharm. Sci., 5 (7) 575-587.
48. Joshi K.A., Dhalani J.M., Bhatt H.B., and Kapadiya K.M. (2021) Synthesis of some new 6-aryl-3-(4-isopropylphenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and its anti-microbial study. Curr. Chem. Lett., 10 (4) 479-488. https://doi.org/10.5267/j.ccl.2021.4.003
49. Prasad S., Pandey A.K., Kumar D., Prasad A., and Gupta C. (2022) Synthesis and biological activities of 3,6-disubsybstituted-1,2,4-triazolo(3,4-b)-1,3,4-thiadiazoles. Indian J. Chem., 61 1288-1294. https://doi.org/10.56042/ijc.v61i12.69476
50. Sahu J.K., Ganguly S., and Yasir M. (2018) Synthesis, SAR and molecular docking studies of certain new derivatives of 1,2,4-triazolo [3,4-b][1,3,4] thiadiazole as potent antimicrobial agents. Anti-Infect. Agents, 16 (1) 40-48. https://doi.org/10.2174/2211352516666180209125045
51. Plech T., Wujec M., Kosikowska U., Malm A., and Kapron B. (2012) Studies on tge synthesis and antibacterial activity of 3,6-disubstituted 1,2,4-triazolo[3,4-b]1,3,4-thiadiazoles. Eur. J. Med. Chem., 47 580-584. https://doi.org/10.1016/j.ejmech.2011.10.055
52. Wu S., Shi J., Chen J., Hu D., Zang L., and Song B. (2021) Synthesis, antibacterial activity, and mechanisms of novel 6-sulfonyl-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives. J. Agric. Food Chem., 69 (16) 4645-4654. https://doi.org/10.1021/acs.jafc.1c01204
53. Zhao B., Wang H., Fan Z., Wu Q., Guo X., Zhang N., Yang D., Yu B., and Zhou S. (2019) Mode of action for a new potential fungicide candidate, 3-(4-methyl-1,2,3-thiadiazolyl)-6-trichloromathyl-[1,2,4]-triazolo-[3,4-b][1,3,4]-thiadiazole by iTRAQ. Food Agric. Immunol., 30 (1) 533-547. https://doi.org/10.1080/09540105.2019.1603287
54. Kamoutsis C., Fesatidou M., Petrou A., Geronikaki A., Poroikov V., Ivanov M., Sokovic M., Ciric A., Carazo A., and Mladenka P. (2021) Triazolo based-thiadiazole derivatives. Synthesis, biological evaluation and molecular docking studies. Antibiotics, 10 (7) 804. https://doi.org/10.3390/antibiotics10070804
55. Al-Soud Y.A., Al-Masoudi N.A., Loddo R., and La Colla P. (2008) In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues. Arch. Pharm. Chem. Life Sci., 341 365-369. https://doi.org/10.1002/ardp.200700272
56. Khan I., Hameed S., Al-Masoudi N.A., Abdul-Reda N.A., and Simpson J. (2015) New triazolothiadiazole and triazolothiadiazine derivatives as kinesin Eg5 and HIV inhibitors: Synthesis, QSAR and modeling studies. Z. Naturforsch. B, 70 (1) 47-58. https://doi.org/10.1515/znb-2014-0162
57. Li Z., Liu Y., Bai X., Deng Q., Wang J., Zhang G., Xiao C., Mei Y., and Wang Y. (2015) SAR studies on 1,2,4-triazolo[3,4-b]thiadiazoles as inhibitors of Mtb shikimate dehydrogenase for the development of novel antitubercular agents. RSC Adv., 5 97089. https://doi.org/10.1039/C5RA19334F
58. Deng Q., Meng J., Liu Y., Guan Y., and Xiao C. (2018) IMB-SD62, a triazolothiadiazole derivative with promising action against tuberculosis. Tuberculosis, 112 37-44. https://doi.org/10.1016/j.tube.2018.07.006
59. Cansiz A., Cetin A., Orek C., Karatepe M., Sarac K., Kus A., and Koparir P. (2012) 6-Phenyl-3-(4-pyridyl)-1,2,4-triazolo-[3,4-b][1,3,4]thiadiazole: Synthesis, experimental, theoretical characterization and biological activities. Spectrochim. Acta A Mol. Biomol. Spectrosc., 97 606-615. https://doi.org/10.1016/j.saa.2012.07.016
60. Seelolla G. and Ponneri V. (2016) Synthesis, antimicrobial, and antioxidant activities of some fused heterocyclic [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. J. Heterocycl. Chem., 53 (3) 929-936. https://doi.org/10.1002/jhet.2348
61. Kamboj V.K., Kapoor A., and Jain S. (2019) Synthesis, antimicrobial, and antioxidant screening of aryl acetic acid incorporated 1,2,4-triazolo-1,3,4-thiadiazole derivatives. J. Heterocycl. Chem., 56 (4) 1376-1382. https://doi.org/10.1002/jhet.3513
62. Malladi S., Isloor A.M., Shetty P., Fun H.K., Telkar S., Mahmood R., and Isloor N. (2012) Synthesis and anti-inflammatory evaluation of some new 3,6-disubstituted-1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazoles bearing pyrazole moiety. Med. Chem. Res., 21 3272-3280. https://doi.org/10.1007/s00044-011-9865-0
63. Chawla G., Kumar U., Bawa S., and Kumar J. (2012) Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. J. Enzyme Inhib. Med. Chem., 27 (5) 658-665. https://doi.org/10.3109/14756366.2011.606543
64. Al-Wahaibi L.H, Akilandeswari G., Anusha R., Al-Shaalan N.H., Alkmali O.M., El-Emam A.A., Percino J.M., and Thamotharan S. (2019) Insights into the nature of weak noncovalent interactions in 3-(4-fluorophenyl)-6-(2-fluorophenyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole, a potential bioactive agent: X-ray, QTAIM and molecular docking analysis, J. Mol. Struct., 1183 331-341. https://doi.org/10.1016/j.molstruc.2019.01.106
65. Sarafroz M., Khatoon Y., Ahmad N., Amir M., Salahuddin, and Pottoo F.H. (2019) Synthesis, characterization and anticonvulsant activity of novel fused 1,2,4-triazolo-1,3,4-thiadiazoles. Orient. J. Chem., 35 (1) 64-70. http://dx.doi.org/10.13005/ojc/350107
66. Settypalli T., Chunduri V.R., Kerru N., Nallapaneni H.K., Chintha V.R., Daggupati T., Yeguvapalli S., and Wudayagiri R. (2019) Design, synthesis, neuroprotective and antibacterial activities of 1,2,4-triazolo[3,4-b] 1,3,4-thiadiazole linked thieno[2,3-d]pyrimidine derivatives and in silico docking studies. ChemistrySelect, 4 1627-1634. https://doi.org/10.1002/slct.201803917
67. Bekircan O., Danış Ö., Şahin M.E., and Çetin M. (2022) Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. Bioorg. Chem., 118 105493. https://doi.org/10.1016/j.bioorg.2021.105493
2. Al-Mulla A. (2017) A review: Biological importance of heterocyclic compounds. Der Pharma Chemica, 9 (13) 141-147.
3. Hamoud M.M.S., Osman N.A., Rezq S., Abd El-Wahab H.A.A., Hassan A.E.A., Abdel-Fattah H.A., Romero D.G., and Chanim A.M. (2022) Design and synthesis of novel 1,3,4-oxadiazole and 1,2,4-triazole derivatives as cyclooxygenase-2 inhibitors with anti-inflammatory and antioxidant activity in LPS-stimulated RAW264.7 macrophages. Bioorg. Chem., 124 105808. https://doi.org/10.1016/j.bioorg.2022.105808
4. Chaban T.I., Matiichuk Y.E., Horishny V.Y., Chaban I.G., and Matiychuk V.S. (2020) Synthesis and anticancer activity of 2-aryl-3-methylbenzofuro[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-dione and 2-aryl-3,7,9-trimethylpyrido[3',2':4,5]thieno[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-diones. Russ. J. Org. Chem., 56 813-818. http://dx.doi.org/10.1134/S1070428020050139
5. Pone K.B., Dalhatou S., Paumo H.K., Katata-Seru L.M., and Ferreira E.I. (2022) Triazole-containing heterocycles: Privileged scaffolds in anti-Trypanosoma Cruzi drug development. Curr. Drug Targets, 23 (1) 33-59. https://doi.org/10.2174/1389450122666210412125643
6. Lelyukh M., Demchuk I., Harkov S., Chaban T., Drapak I., Chaban I., Shelepeten L., and Matiychuk V. (2020) A review on synthetic routes for obtaining of 2,5-disubstituted 1,3,4-oxadiazoles via cyclodehydration and oxidative cyclization reactions. Biointerface Res. Appl. Chem., 10 (4) 5960-5971. https://doi.org/10.33263/BRIAC104.960971
7. Longo Jr, L.S. and Siqueira F.A. (2024) Synthesis of imidazo[2,1-b]thiazol-5-amines using Groebke-Blackburn-Bienaymé multicomponent reaction (microreview). Chem. Heterocycl. Compd., 60 (7/8) 339-341.
8. Chaban T.I., Lelyukh M.I., Chaban I.H., and Kasyanchuk O.Y. (2024) Approaches to the synthesis of thiazolo[3,2-a]pyridines (microreview). Chem. Heterocycl. Compd., 60 (3/4) 124-126.
9. Drapak I., Chaban T., Foliush V., and Matiychuk V. (2020) Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl)thiazol-2-ylimino]thiazolidin-4-ones. Biointerface Res. Appl. Chem., 10 (3) 5507-5511. https://doi.org/10.33263/BRIAC103.507511
10. Subtelna I., Kryshchyshyn-Dylevych A., Jia R., Lelyukh M., Ringler A., Kubicek S., Zagrijtschuk O., Kralovics R., and Lesyk R. (2021) 5-Arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones with selective inhibitory activity against some leukemia cell line. Arch. Pharm., 354 (4) 2000342. https://doi.org/10.1002/ardp.202000342
11. Сhulovska Z., Chaban T., Drapak I., Matiychuk V., Chaban I., and Nektegaev I. (2021) Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents. Biointerface Res. Appl. Chem., 11 (1) 8009-8017. https://doi.org/10.33263/BRIAC111.80098017
12. Lingappa M., Guruswamy V., and Bantal V. (2021) Synthesis and characterization of 4-amino-4H-1,2,4-triazole derivatives: Anticonvulsant activity. Curr. Chem. Lett., 10 (1) 33-42. https://doi.org/10.5267/j.ccl.2020.7.002
13. Lelyukh M., Matiichuk Yu., Flud V., Chaban I., and Ogurtsov V. (2022) Synthesis and antioxidant properties of novel 2-(2,4-dioxothiazolidin-5-ylidene)-acetamides containing 1,3,4-thia/oxadiazole moieties. Biointerface Res. Appl. Chem., 12 (5) 6710-6722. https://doi.org/10.33263/BRIAC125.67106722
14. Lelyukh M., Halevych H., Zhukrovska M., Semiion-Luchyshyn O., and Kalytovska M. (2023) Synthesis of 5-aryl/heterylidene substituted 2-imino-4-thiazolidinones possessing 1,3,4-thiadiazole moiety and their antitrypanosomal activity. Curr. Chem. Lett., 12 (2) 413-420. https://doi.org/10.5267/j.ccl.2022.11.005
15. Chaban T.I., Klenina O.V., Chaban I.H., and Lelyukh M.I. (2024) Recent advances in the synthesis of thiazolo[4,5-b]pyridines. Part 2: Focus on thiazole annulation to pyridine ring (microreview). Chem. Heterocycl. Compd., 60, (3-4) 130-132.
16. Chulovska Z., Chaban T., Savchenko A., Komarytsya O., Dasho M., Lelyukh M., Chaban I., and Ogurtsov V. (2025) Antioxidant properties of some 4-arylimino-thiazolidin-2-ones. Curr. Chem. Lett., 14 (2) 365-372. https://doi.org/10.5267/j.ccl.2024.11.001
17. Charitos G., Trafalis D.T., Dalezis P., Polamitis C., Sarli V., Zoumpoulakis P., and Camoutsis C. (2019) Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives. Arab. J. Chem., 12 (8) 4784-4794. https://doi.org/10.1016/j.arabjc.2016.09.015
18. Pundeer R., Ranjan P., Prakash R., and Joshi R. (2018) Synthesis of novel 6-(1H-pyrazol-4-yl)-[1,2,4]triazolo[3,4-b]thiadiazoles as potential antimicrobial agents. Lett. Org. Chem., 15 (2) 92-97. https://doi.org/10.2174/1570178614666170907121125
19. Idrees M., Kola S.S., and Siddiqui N.J. (2019) Facile synthesis, characterization and antimicrobial activities of novel 6-amino triazolo-thiadiazoles integrated with benzofuran and pyrazole moieties. Oriet. J. Chem., 35 (6) 1712-1717. http://dx.doi.org/10.13005/ojc/350612
20. Gao W., Zhang Y., Chen L., Liu X., Li K., Han L., Yu Z., Ren J., Tang L., and Fan. Z. (2022) Novel [1,2,4]-triazolo[3,4-b]thiadiazoles as potent pyruvate kinase inhibitors for fungal control. J. Agric. Food Chem., 70 (33) 10170-10181. https://doi.org/10.1021/acs.jafc.2c03758
21. Maddila S., Gorle S., Singh M., Lavanya P., and Jonnalagadda S.B. (2013) Synthesis and anti-inflammatory activity of fused 1,2,4-triazolo-[3,4-b] [1,3,4]thiadiazole derivatives of phenothiazine. Lett. Drug. Des. Discov., 10 (10) 977-983.
22. Dighe A.S. and Sen A.K. (2021) In silico investigation and molecular docking study of triazolo-thiadiazole derivatives for antimicrobial, anti-inlammatory and anti-diabetic activity. Indian J. Pharm. Educ. Res., 55 (4) 1125-1144. https://doi.org/10.5530/ijper.55.4.213
23. Himaja M., Prathap K.J., and Mali S.V. (2012) Facile synthesis of 3,6-disubstituted-1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazoles via oxidative cyclization of n-heteroaryl-substituted hydrazones and their biological activity. J. Heterocycl. Chem., 49 (4) 823-828. https://doi.org/10.1002/jhet.870
24. Khatoon Y., Singh V., and Sarafroz M. (2018) Anticonvulsant and neurotoxicity evaluation of some fused 1,2,4-triazole-[3,4-b]-1,3,4-thiadiazole derivatives. Int. J. Pharm. Sci. Rev. Res., 48 (2) 70-78.
25. Tozkoparan B., Pery Aytac S., Gursoy S., Gunal S., and Aktay G. (2012) Novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives as dual analgesic/anti-inflammatory and antimicrobial agents. Lett. Drug. Des. Discov., 9 (2) 204-212.
26. Jubie S., Ramesh P.N., Dhanabal P., Kalirajan R., Muruganantham N., and Antony A.S. (2012) Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues. Eur. J. Med. Chem., 54 931-935. https://doi.org/10.1016/j.ejmech.2012.06.025
27. Akhter Mohd. W., Hassan Mohd. Z., and Amir Mohd. (2014) Synthesis and pharmacological evaluation of 3-diphenylmethyl-6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles: A condensed bridgehead nitrogen heterocyclic system. Arab. J. Chem, 7 (6) 955-963. https://doi.org/10.1016/j.arabjc.2014.05.036
28. Wu J., Li J., Xu M.-H., and Liu D. (2014) Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole. Bioorg. Med. Chem. Lett., 24 (14) 3050-356. https://doi.org/10.1016/j.bmcl.2014.05.028
29. Llona-Minguez S., Höglund A., Wiita E., Almlöf I., Mateus A., Calderón-Montaño J.M., Cazares-Körner C., Homan E., Loseva O., Baranczewski P., Jemth A.-S., Häggblad M., Martens U., Lundgren B., Artursson P., Lundbäck T., Jensen A.J., Berglund U.W., Scobie M., and Helleday T. (2017) Identification of triazolothiadiazoles as potent inhibitors of the dCTP pyrophosphatase 1. J. Med. Chem., 60 (5) 2148-2154. https://doi.org/10.1021/acs.jmedchem.6b01786
30. Bonafoux D., Nanthakumar S., Bandarage U.K., Memmott C., Lowe D.B., Aronov A.M., Rao G.B., Bonanno K., Coll J., Leeman J., Lepre C.A., Lu F., Perola E., Rijnbrand R., Taylor W.P., Wilson D., Zhou Y., Zwahlen J., and ter Haar E. (2016) Fragment-based discovery of dual JC virus and BK virus helicase inhibitors. J. Med. Chem., 59 (15) 7138-7151. https://doi.org/10.1021/acs.jmedchem.6b00486
31. Zhang J., Liu H., Zhu K., Gong S., Dramsi S., Wang Y.-T., Li J., Chen F., Zhang R., Zhou L., Lan L., Jiang H., Schneewind O., Luo C., and Yang C.-G. (2014) Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase. Proc. Natl. Acad. Sci., 111 (37) 13517-13522. https://doi.org/10.1073/pnas.1408601111
32. Fan J.-Z., Li J.-P., Zhang L.-P., Zhang L.-G., and Wang D.-Z. (2015) New CuII and CdII metal-organic coordination polymers with 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole ligands: Syntheses, structures and luminescent properties. J. Chin. Chem. Soc., 62 (9) 786-792.
33. Jubie S., Bincy B., Begam A.J., Ashish W., Kalirajan R., and Azam Md A. (2018) A new class of human fatty acid synthase inhibitors: Synthesis and their anticancer evaluation. Indian J. Chem., 57B 671-678.
34. Lelyukh M., Adamchuk S., Harkov S., Chaban I., Demchuk I., Shelepeten L., and Chaban T. (2018) Synthetic approaches, chemical modification and biological activity of non-condensed 1,3,4-thiadiazole derivatives: A review. Pharmacia, 65 (4) 72-88.
35. Lelyukh M., Zhukrovska M., Komarenska Z., Flud V., and Harkov S. (2023) Synthetic approaches, modification ability and biological activity of 1,3,4-thiadiazole based [5+5] annelated heterosystems: Mini-review. Curr. Chem. Lett., 12 (4) 769-780. https://doi.org/10.5267/j.ccl.2023.4.004
36. Lelyukh M., Paliy A., Zhukrovska M., Kalytovska M., Chaban I., Shelepeten L., and Chaban T. (2024) A review on synthetic approaches for obtaining and chemical modification of 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole based heterocyclic compounds. Curr. Chem. Lett., 13 (4) 737-752. https://doi.org/10.5267/j.ccl.2024.3.007
37. Lelyukh M.I., Komarenska Z.M., Chaban T.I., and Chaban I.H. (2024) An overview of the synthetic routes toward [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles (microreview). Chem. Heterocycl. Compd., 60 (7/8) 342-344.
38. Xu Q., Sun M., Bai Z., Wang Y., Wu Y., Tian H., Zuo D., Guan Q., Bao K., Wu Y., and Zhang W. (2017) Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. Eur. J. Med. Chem., 139 242-249. https://doi.org/10.1016/j.ejmech.2017.05.065
39. Sunil D., Isloor A.M., Shetty P., Satyamoorthy K., and Prasad A.S.B. (2011) Synthesis, characterization, antioxidant, and anticancer studies of 6-[3-(4-chlorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b][1,3,4]thiadiazole in HepG2 cell lines. Med. Chem. Res., 20 1074-1080. https://doi.org/10.1007/s00044-010-9436-9
40. Trafalis D.T., Sagredou S., Dalezis P., Voura M., Fountoulaki S., Nikoleousakos N., Almpanakis K., Deligiorgi M.V., and Sarli V. (2021) Anticancer activity of triazolo-thiadiazole derivatives and inhibition of AKT1 and AKT2 activation. Pharmaceutics, 13 493. https://doi.org/10.3390/pharmaceutics13040493
41. Liu X.-J., Liu H.-Y., Wang H.-X., Shi Y.-P., Tang R., Zhang S., and Chen B.-Q. (2019) Synthesis and antitumor evaluation of novel fused heterocyclic 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. Med. Chem. Res., 28 1718-1725. https://doi.org/10.1007/s00044-019-02409-2
42. Zhang L., Zhao J., Zhang B., Lu T., and Chen Y. (2018) Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. Eur. J. Med. Chem., 150 809-816. https://doi.org/10.1016/j.ejmech.2018.03.049
43. Hamdy R., Jones A.T., El-Sadek M., Hamoda A.M., Shakartalla S.B., Al Shareef Z.M., Soliman S.S.M., and Westwell A.D. (2021) New bioactive fused triazolothiadiazoles as Bcl-2-Targeted anticancer agents. Int. J. Mol. Sci., 22 (22) 12272. https://doi.org/10.3390/ijms222212272
44. Sagredou S., Dalezis P., Nikoleousakos N., Nikolaou M., Voura M., Almpanakis K., Panayiotidis M.I., Sarli V., and Trafalis D.T. (2020) 3,6-Disubstituted 1,2,4-triazolo[3,4-b]thiadiazoles with anticancer activity targeting topoisomerase II alpha. Onco Targets Ther., 13 7369-7386. http://doi.org/10.2147/OTT.S254856
45. Barash U., Rangappa S., Mohan C.D., Vishwanath D., Boyango I., Basappa B., Vlodavsky I., and Rangappa K.S. (2021) New heparanase-inhibiting triazolo-thiadiazoles attenuate primary tumor growth and metastasis. Cancers, 13 (12) 2959. https://doi.org/10.3390/cancers13122959
46. Sahu J.K., Ganguly S., and Kaushik A. (2014) Synthesis of some novel heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] thiadiazole derivatives as possible antimicrobial agents. J. Appl. Pharm. Sci., 4 (02) 081-086. https://doi.org/10.7324/JAPS.2014.40214
47. Triloknadh S., Rao C.V., Nagaraju B., Balagi H., and Balaji M. (2018) Design and synthesis of novel 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]1,3,4-thiadiazole derivatives and their antimicrobial studies. Eur. J. Biomed. Pharm. Sci., 5 (7) 575-587.
48. Joshi K.A., Dhalani J.M., Bhatt H.B., and Kapadiya K.M. (2021) Synthesis of some new 6-aryl-3-(4-isopropylphenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and its anti-microbial study. Curr. Chem. Lett., 10 (4) 479-488. https://doi.org/10.5267/j.ccl.2021.4.003
49. Prasad S., Pandey A.K., Kumar D., Prasad A., and Gupta C. (2022) Synthesis and biological activities of 3,6-disubsybstituted-1,2,4-triazolo(3,4-b)-1,3,4-thiadiazoles. Indian J. Chem., 61 1288-1294. https://doi.org/10.56042/ijc.v61i12.69476
50. Sahu J.K., Ganguly S., and Yasir M. (2018) Synthesis, SAR and molecular docking studies of certain new derivatives of 1,2,4-triazolo [3,4-b][1,3,4] thiadiazole as potent antimicrobial agents. Anti-Infect. Agents, 16 (1) 40-48. https://doi.org/10.2174/2211352516666180209125045
51. Plech T., Wujec M., Kosikowska U., Malm A., and Kapron B. (2012) Studies on tge synthesis and antibacterial activity of 3,6-disubstituted 1,2,4-triazolo[3,4-b]1,3,4-thiadiazoles. Eur. J. Med. Chem., 47 580-584. https://doi.org/10.1016/j.ejmech.2011.10.055
52. Wu S., Shi J., Chen J., Hu D., Zang L., and Song B. (2021) Synthesis, antibacterial activity, and mechanisms of novel 6-sulfonyl-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives. J. Agric. Food Chem., 69 (16) 4645-4654. https://doi.org/10.1021/acs.jafc.1c01204
53. Zhao B., Wang H., Fan Z., Wu Q., Guo X., Zhang N., Yang D., Yu B., and Zhou S. (2019) Mode of action for a new potential fungicide candidate, 3-(4-methyl-1,2,3-thiadiazolyl)-6-trichloromathyl-[1,2,4]-triazolo-[3,4-b][1,3,4]-thiadiazole by iTRAQ. Food Agric. Immunol., 30 (1) 533-547. https://doi.org/10.1080/09540105.2019.1603287
54. Kamoutsis C., Fesatidou M., Petrou A., Geronikaki A., Poroikov V., Ivanov M., Sokovic M., Ciric A., Carazo A., and Mladenka P. (2021) Triazolo based-thiadiazole derivatives. Synthesis, biological evaluation and molecular docking studies. Antibiotics, 10 (7) 804. https://doi.org/10.3390/antibiotics10070804
55. Al-Soud Y.A., Al-Masoudi N.A., Loddo R., and La Colla P. (2008) In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues. Arch. Pharm. Chem. Life Sci., 341 365-369. https://doi.org/10.1002/ardp.200700272
56. Khan I., Hameed S., Al-Masoudi N.A., Abdul-Reda N.A., and Simpson J. (2015) New triazolothiadiazole and triazolothiadiazine derivatives as kinesin Eg5 and HIV inhibitors: Synthesis, QSAR and modeling studies. Z. Naturforsch. B, 70 (1) 47-58. https://doi.org/10.1515/znb-2014-0162
57. Li Z., Liu Y., Bai X., Deng Q., Wang J., Zhang G., Xiao C., Mei Y., and Wang Y. (2015) SAR studies on 1,2,4-triazolo[3,4-b]thiadiazoles as inhibitors of Mtb shikimate dehydrogenase for the development of novel antitubercular agents. RSC Adv., 5 97089. https://doi.org/10.1039/C5RA19334F
58. Deng Q., Meng J., Liu Y., Guan Y., and Xiao C. (2018) IMB-SD62, a triazolothiadiazole derivative with promising action against tuberculosis. Tuberculosis, 112 37-44. https://doi.org/10.1016/j.tube.2018.07.006
59. Cansiz A., Cetin A., Orek C., Karatepe M., Sarac K., Kus A., and Koparir P. (2012) 6-Phenyl-3-(4-pyridyl)-1,2,4-triazolo-[3,4-b][1,3,4]thiadiazole: Synthesis, experimental, theoretical characterization and biological activities. Spectrochim. Acta A Mol. Biomol. Spectrosc., 97 606-615. https://doi.org/10.1016/j.saa.2012.07.016
60. Seelolla G. and Ponneri V. (2016) Synthesis, antimicrobial, and antioxidant activities of some fused heterocyclic [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. J. Heterocycl. Chem., 53 (3) 929-936. https://doi.org/10.1002/jhet.2348
61. Kamboj V.K., Kapoor A., and Jain S. (2019) Synthesis, antimicrobial, and antioxidant screening of aryl acetic acid incorporated 1,2,4-triazolo-1,3,4-thiadiazole derivatives. J. Heterocycl. Chem., 56 (4) 1376-1382. https://doi.org/10.1002/jhet.3513
62. Malladi S., Isloor A.M., Shetty P., Fun H.K., Telkar S., Mahmood R., and Isloor N. (2012) Synthesis and anti-inflammatory evaluation of some new 3,6-disubstituted-1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazoles bearing pyrazole moiety. Med. Chem. Res., 21 3272-3280. https://doi.org/10.1007/s00044-011-9865-0
63. Chawla G., Kumar U., Bawa S., and Kumar J. (2012) Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. J. Enzyme Inhib. Med. Chem., 27 (5) 658-665. https://doi.org/10.3109/14756366.2011.606543
64. Al-Wahaibi L.H, Akilandeswari G., Anusha R., Al-Shaalan N.H., Alkmali O.M., El-Emam A.A., Percino J.M., and Thamotharan S. (2019) Insights into the nature of weak noncovalent interactions in 3-(4-fluorophenyl)-6-(2-fluorophenyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole, a potential bioactive agent: X-ray, QTAIM and molecular docking analysis, J. Mol. Struct., 1183 331-341. https://doi.org/10.1016/j.molstruc.2019.01.106
65. Sarafroz M., Khatoon Y., Ahmad N., Amir M., Salahuddin, and Pottoo F.H. (2019) Synthesis, characterization and anticonvulsant activity of novel fused 1,2,4-triazolo-1,3,4-thiadiazoles. Orient. J. Chem., 35 (1) 64-70. http://dx.doi.org/10.13005/ojc/350107
66. Settypalli T., Chunduri V.R., Kerru N., Nallapaneni H.K., Chintha V.R., Daggupati T., Yeguvapalli S., and Wudayagiri R. (2019) Design, synthesis, neuroprotective and antibacterial activities of 1,2,4-triazolo[3,4-b] 1,3,4-thiadiazole linked thieno[2,3-d]pyrimidine derivatives and in silico docking studies. ChemistrySelect, 4 1627-1634. https://doi.org/10.1002/slct.201803917
67. Bekircan O., Danış Ö., Şahin M.E., and Çetin M. (2022) Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. Bioorg. Chem., 118 105493. https://doi.org/10.1016/j.bioorg.2021.105493